Skip to main content
logo
Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
16.26
-0.33 (-1.99%)
At close: Oct 10, 2025, 4:00 PM EDT
16.00
-0.26 (-1.60%)
After-hours: Oct 10, 2025, 5:13 PM EDT

Aardvark Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2024
Period Ending
Dec '24 Dec '23
Net Income
-20.59-7.21
Depreciation & Amortization
0.02-
Stock-Based Compensation
0.440.31
Other Adjustments
0.471.15
Changes in Accounts Payable
0.80.78
Changes in Accrued Expenses
1.39-0
Changes in Other Operating Activities
-0.61-0.86
Operating Cash Flow
-18.09-5.82
Capital Expenditures
-0.11-
Purchases of Investments
-11.89-
Investing Cash Flow
-12-
Issuance of Common Stock
0.33-
Net Common Stock Issued (Repurchased)
0.33-
Issuance of Preferred Stock
85-
Net Preferred Stock Issued (Repurchased)
85-
Other Financing Activities
-3.34-
Financing Cash Flow
81.99-
Net Cash Flow
51.91-5.82
Beginning Cash & Cash Equivalents
9.7415.56
Ending Cash & Cash Equivalents
61.649.74
Free Cash Flow
-18.2-5.82
Free Cash Flow Per Share
-4.55-1.47
Levered Free Cash Flow
-19.11-7.29
Unlevered Free Cash Flow
-21.31-7.5
Updated Aug 13, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q